.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Harvard Business School
Accenture
QuintilesIMS
Mallinckrodt
Medtronic
UBS
Colorcon
Federal Trade Commission

Generated: November 19, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: propranolol hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sandoz Inc
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
INJECTABLE;INJECTION076400ANDACardinal Health55154-5445-81 VIAL, SINGLE-USE in 1 BAG (55154-5445-8) > 1 mL in 1 VIAL, SINGLE-USE
Rp Scherer
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078703ANDAAvKARE, Inc.42291-522-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-522-01)
Rp Scherer
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078703ANDAAvKARE, Inc.42291-522-101000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-522-10)
Rp Scherer
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078703ANDAAvKARE, Inc.42291-523-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-523-01)
Rp Scherer
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078703ANDAAvKARE, Inc.42291-523-101000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-523-10)
Rp Scherer
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078703ANDAAvKARE, Inc.42291-524-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-524-01)
Rp Scherer
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078703ANDAAvKARE, Inc.42291-524-101000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-524-10)
Rp Scherer
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078703ANDAAvKARE, Inc.42291-525-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-525-01)
Rp Scherer
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078703ANDAAvKARE, Inc.42291-525-101000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-525-10)
Rp Scherer
PROPRANOLOL HYDROCHLORIDE
propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078703ANDABreckenridge Pharmaceutical, Inc.51991-817-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51991-817-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Baxter
Queensland Health
Argus Health
Colorcon
Julphar
Cantor Fitzgerald
Teva
AstraZeneca
QuintilesIMS

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot